Insmed (INSM) Total Current Liabilities (2010 - 2026)

Insmed's (INSM) quarterly Total Current Liabilities came in at $361.0 million in Q1 2026, up 50.9% year-on-year from $239.2 million in Q1 2025, and down 23.01% quarter-over-quarter from $468.9 million in Q4 2025.

Insmed (INSM) Total Current Liabilities (2010 - 2026) Analysis & Trends

Insmed's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $361.0 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 50.9% year-over-year to $361.0 million in Q1 2026; TTM through Mar 2026 was $361.0 million, a 50.9% increase from a year earlier, with the FY2025 full-year figure at $468.9 million, up 57.59% from the prior year.
  • Total Current Liabilities slipped to $361.0 million in Q1 2026 per INSM's latest filing, from $468.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $524.2 million in Q2 2024 and bottomed at $113.8 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $239.2 million (2025), against an average of $275.4 million.
  • Across the five-year window, Total Current Liabilities soared 156.61% in 2024 and tumbled 43.16% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $190.2 million in 2022, then climbed by 18.6% to $225.6 million in 2023, then jumped by 31.87% to $297.5 million in 2024, then soared by 57.59% to $468.9 million in 2025, then slipped by 23.01% to $361.0 million in 2026.
  • Per Business Quant, the three latest INSM Total Current Liabilities figures stand at $361.0 million (Q1 2026), $468.9 million (Q4 2025), and $417.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn 361.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 361.01 Mn
Dec 31, 2025 468.87 Mn
Sep 30, 2025 417.21 Mn
Jun 30, 2025 311.68 Mn
Mar 31, 2025 239.23 Mn
Dec 31, 2024 297.53 Mn
Sep 30, 2024 259.19 Mn
Jun 30, 2024 524.15 Mn
Mar 31, 2024 420.86 Mn
Dec 31, 2023 225.63 Mn
Sep 30, 2023 196.73 Mn
Jun 30, 2023 204.26 Mn
Mar 31, 2023 187.98 Mn
Dec 31, 2022 190.24 Mn
Sep 30, 2022 137.65 Mn
Jun 30, 2022 113.82 Mn
Mar 31, 2022 125.25 Mn
Dec 31, 2021 135.17 Mn
Sep 30, 2021 112.50 Mn
Jun 30, 2021 99.66 Mn